Damon Runyon Physician-Scientist Training Award
In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon Cancer Research Foundation is establishing a pilot program designed to recruit outstanding U.S. Specialty Board-eligible physicians into cancer research careers. The goals are to a) transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer and b) to eliminate the financial disincentive to entering this career path.
This award will provide a funding source that will enable these individuals to pursue research intensively, while, if they wish to maintain their clinical skills, continuing to be clinically active. This award is structured to provide recipients with significant salary support and necessary research expenses (up to $460,000 over four years). In addition, the Foundation will retire up to $100,000 of any medical school debt still owed by an award recipient.
Application Deadline: December 1, 2015
The Lion Heart Fund for Cancer Research
The Lion Hearts are committed to finding a cure for cancer, and breast cancer in particular. In keeping with this mission, they understand the value of funding bright young minds – providing them with pilot funding to kick-start high potential research projects, and/or supporting innovative work requiring bridge funding. The Yale Cancer Center/Smilow Cancer Hospital, and particularly the Breast Center, are solid partners of the Lion Hearts and have a wealth of scientists and clinicians who are working hard towards the same goal. The Lion Heart Fund for Cancer Research was developed in order to move this shared vision forward.
Applications will be judged based on:
a) Significance, and potential impact
d) Degree to which the proposal is aligned with Lion Heart goals
Deadline for Proposals: November 20, 2015
Tobacco Center of Regulatory Science 2016 Pilot Project Program Announcement
The Yale Tobacco Center of Regulatory Science (TCORS) is offering funding for pilot projects to initiate
research relating to understanding tobacco additives and modified risk tobacco products through
behavioral, molecular, laboratory, pharmacological, epidemiological, and economic sciences that
involves humans (both clinical & epidemiological research) and animals (basic research). We are
particularly interested in studies of menthol, flavors, sweeteners, and e-cigarettes and studies using novel
Up to 3-5 pilot projects will be funded at the level of $25,000 to $75,000 (direct costs only). The project
must be completed in 1 budget year. Collaborative studies between Yale TCORS and one or more other
TCORS are encouraged. Prior permission for a cross-TCORS collaborative proposal is required.
Application Deadline: December 7, 2015 by 4:00 pm
NCCN Request for Proposals (RFP): Preclinical, Phase I/II Clinical Trials and Correlative Studies of Afatinib in Combination with Other Drugs for Selected Cancers
Boehringer Ingelheim Pharmaceuticals, Inc. (hereafter, “Grantor”) has agreed to provide National Comprehensive Cancer Network (NCCN) a 2 Million Dollar research grant to support NCCN Member Institution faculty for the performance of preclinical, clinical, and correlative studies of afatinib containing combinations in the treatment of lung and head and neck cancers. NCCN will serve as the funding organization for these grants that are available only to NCCN investigators. The following details the objectives, process and requirements of this RFP, which shall be subject to the terms and conditions of the Research Agreement.
The motivation behind this RFP is to facilitate the development of combination therapies using afatinib. Towards this goal, several specific additional therapies may be available from collaborating pharmaceutical companies, and are detailed below, though investigations addressing any combination regimens will be considered.
All proposals must be submitted electronically using the directions below and are due by 5:00 PM (EST) on January 4, 2016
. For additional information, please contact Doreen Walker, Administrative Assistant, Oncology Research Program, at (215) 690-0565 or via email at Walker@nccn.org
Lymphatic Education & Research Network Postdoctoral Fellowship Awards Program
The Lymphatic Education & Research Network (LE&RN) is committed to supporting basic and translational research that fosters an interdisciplinary field of investigators conducting lymphatic research. The supported research will improve our understanding and advance the prevention, diagnosis, and novel treatments of lymphedema and other lymphatic disorders. In each grant cycle, at least one fellowship will specifically focus on lymphedema.
Application Deadline: January 15, 2016
L’Oréal-UNESCO For Women in Science Fellowship Program Award
The L’Oréal-UNESCO For Women in Science program recognizes and rewards the contributions women make in STEM fields and identifies exceptional women researchers committed to serving as role models for younger generations. More than 2,250 women scientists in over 110 countries have been recognized since the program began in 1998.
In the US, the For Women In Science fellowship program awards five post-doctoral women scientists annually with grants of $60,000 each. Applicants are selected from a variety of fields, including the life and physical/material sciences, technology (including computer science), engineering, and mathematics.
I invite you to collaborate with us and spread the word to your community about this special fellowship program for exceptional female post-doctoral researchers who are also committed to serving as role models for the next generation of girls in STEM.
Applications will open on November 30, 2015 and are due by February 5, 2016.Learn More>>
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.
Application Due Date: Application Receipt/Submission Date(s): February 17, 2016; August 16, 2016; February 15, 2017; August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.